Share on StockTwits

Several investment firms have updated their stock ratings and price targets on shares of BioDelivery Sciences International (NASDAQ: BDSI) in the last week:

  • BioDelivery Sciences International had its price target raised by analysts at Piper Jaffray to $24.00.
  • BioDelivery Sciences International had its “outperform” rating reaffirmed by analysts at William Blair. They now have a $23.00 price target on the stock.
  • BioDelivery Sciences International had its price target raised by analysts at Roth Capital to $15.50. They now have a “buy” rating on the stock.
  • BioDelivery Sciences International had its price target raised by analysts at Ladenburg Thalmann to $18.00. They now have a “buy” rating on the stock.
  • BioDelivery Sciences International had its “buy” rating reaffirmed by analysts at Laidlaw. They now have a $15.00 price target on the stock.

Shares of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) traded up 1.42% during mid-day trading on Tuesday, hitting $9.99. 890,652 shares of the company’s stock traded hands. BioDelivery Sciences International, Inc. has a 1-year low of $3.86 and a 1-year high of $10.35. The stock has a 50-day moving average of $9.0 and a 200-day moving average of $7.74. The company’s market cap is $483.9 million.

BioDelivery Sciences International, Inc (NASDAQ:BDSI) is a specialty pharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.